Press Release: AMCP CEO Susan A. Cantrell, RPh, CAE, comments on today's unanimous vote by the House Energy & Commerce (E&C) Committee to approve legislation reauthorizing the FDA’s user fee programs.
Press Release: To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications based on their value.
The Academy of Managed Care Pharmacy (AMCP) thanks the Institute of Clinical and Economic Review (ICER) for the opportunity to provide comments on the draft evidence report titled “Abuse Deterrent Formulations (ADFs) of Opioids: Effectiveness and Value” released on May 5, 2017.
The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of Senate Bill 4788 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.
The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of House Bill 4472 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists. We strongly support the language in the Bill that allows a pharmacist to substitute an FDA approved “interchangeable biological product.”